Search results for "TRIAL"

showing 10 items of 10525 documents

Head Injury Criterion: mini review

2019

Head Injury Criterion (HIC) is the most important parameter in terms of human survival; it is indicative of brain injuries due to the impact of the head in numerous cases, with a vehicle. This index can be estimated by integrating the resulting acceleration of the head (measured in its gravity center) in a time window

medicine.medical_specialtybusiness.industryHead injury criterionAISMini reviewSettore ING-IND/14 - Progettazione Meccanica E Costruzione Di MacchinePhysical medicine and rehabilitationmedicineSettore ING-IND/10 - Fisica Tecnica IndustrialeGeneral Earth and Planetary SciencesbusinessSettore ING-IND/15 - Disegno E Metodi Dell'Ingegneria IndustrialeHICGeneral Environmental Science
researchProduct

Interventional and surgical modalities of treatment for pulmonary arterial hypertension

2004

AbstractBeyond medical therapy, different interventional and surgical approaches exist for treatment of pulmonary arterial hypertension (PAH). Atrial septostomy has been applied in patients with lack of response to medical therapy in the absence of other surgical treatment options. With growing experience, procedure-related death rates have been reduced to 5.4%, and the most suitable patient group has been identified among patients with a mean right atrial pressure between 10 and 20 mm Hg. Pulmonary endarterectomy is the accepted form of treatment for patients with chronic thromboembolic pulmonary hypertension. Establishing the diagnosis and the classification of the type of lesions by pulm…

medicine.medical_specialtybusiness.industryHeart-Lung Transplantationmedicine.medical_treatmentHypertension PulmonaryPatient SelectionRespiratory diseasePerioperativeEndarterectomyPulmonary Arterymedicine.diseasePulmonary hypertensionSurgeryCatheterizationTransplantationIdiopathic pulmonary fibrosisInternal medicinemedicinePulmonary angiographyCardiologyHumansAtrial septostomyCardiology and Cardiovascular MedicinebusinessEndarterectomyJournal of the American College of Cardiology
researchProduct

Early Markers of Cardiovascular Damage

1998

Cardiovascular (CV) disease represents at present one of the most frequent causes of morbidity and mortality in western industrialized countries. The prevalence of CV disease is increased in subjects with hypertension (HTN), diabetes mellitus (DM), dyslipidemia and central obesity. In these conditions, it is possible to detect early alterations of metabolic, hormonal, hemostatic, genetic and hemodynamic parameters, frequently associated with morphological and functional modifications of the left ventricle (LV) and the vascular system. Since these changes generally precede and are closely related to the occurrence of CV events, they may be considered early markers of CV disease. In recent ye…

medicine.medical_specialtybusiness.industryHemodynamicsDiseasemedicine.diseaseBrain natriuretic peptideObesitymedicine.anatomical_structureAtrial natriuretic peptideVentricleDiabetes mellitusInternal medicinemedicineCardiologybusinessDyslipidemia
researchProduct

Video-assisted surgery: suggestions for failure prevention in laparoscopic cholecystectomy

2014

Background: Surgery differs from other medical specialties in its execution. It is often complex and includes considerable individual variations. Observing problems in operating theatres (OT) allows for the identification of system failures which should be defined for learning purposes to increase patient safety and enhance general safety culture within hospital organizations. This study evaluates a common video-assisted surgical procedure, laparoscopic cholecystectomy (LC) through failure analysis. The profile of the LC procedure and failure sources is presented. Methods: Data consisted video-observations and interviews concerning twelve LC operations performed at a day surgery unit. All o…

medicine.medical_specialtybusiness.industryHuman factors and ergonomicsvideo observationCystic arteryVideo-Assisted Surgeryfailure analysisComputer Science ApplicationsSurgeryHuman-Computer InteractionPhilosophyPatient safetymedicine.anatomical_structuremedicine.arterysystem failuresmedicineTask analysisCystic ductOperations managementIndustrial and organizational psychologySafety culturesurgical workbusinesslaparoscopic cholecystectomyinhimilliset tekijätCognition, Technology & Work
researchProduct

Randomized Trial of Lenalidomide and Dexamethasone Versus Clarythromycin, Lenalidomide and Dexamethasone As First Line Treatment in Patients with Mul…

2019

Continuous treatment with lenalidomide (R) and dexamethasone (d) is a standard of care for multiple myeloma (MM) patients (pts) not candidates for autologous stem cell transplantation (ASCT). As previously reported, the addition of Clarithromycin (C) to Rd has proven to be safe and effective, and case-control analyses suggested a significant additive value with the combination. C optimizes the therapeutic effect of glucocorticoids by increasing the area under the curve, has immunomodulatory effects and may have direct antineoplastic properties. However, there are not randomized phase III trials confirming these results. GEM-Claridex in an open, randomized, phase III trial for untreated new…

medicine.medical_specialtybusiness.industryImmunologyDisease progressionCell BiologyHematologymedicine.diseaseBiochemistrylaw.inventionTransplantationClinical trialAutologous stem-cell transplantationRandomized controlled triallawInternal medicinemedicineIn patientbusinessMultiple myelomaLenalidomidemedicine.drugBlood
researchProduct

Rituximab in Combination with CHOP in Patients with Follicular Lymphoma: Analysis of Treatment Outcome of 552 Patients Treated in a Randomized Trial …

2008

Abstract We have previously reported that compared to CHOP alone the addition of Rituximab (R) to CHOP significantly increases the response rate (RR), the time to treatment failure (TTF) and also the overall survival (OS) in patients with newly diagnosed advanced follicular lymphoma. However, in the previous report, the median observation time was short with 18 months and no data were reported on the outcome of different risk groups according to the FLIPI (Hiddemann et al., Blood 2005). We now report on the treatment outcome of 552 patients with advanced stage follicular lymphoma randomized between R-CHOP versus CHOP alone after a median follow up of 58 months. Responding patients < …

medicine.medical_specialtybusiness.industryImmunologyFollicular lymphomaAlpha interferonCell BiologyHematologyCHOPDebulkingmedicine.diseaseBiochemistryChemotherapy regimenGastroenterologySurgerylaw.inventionRandomized controlled trialMedian follow-uplawInternal medicinemedicineRituximabbusinessmedicine.drugBlood
researchProduct

A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria

2016

medicine.medical_specialtybusiness.industryImmunologyQuilizumablaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemRandomized controlled trialRefractorylawInternal medicineImmunology and AllergyMedicinebusinessJournal of Allergy and Clinical Immunology
researchProduct

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial C…

2020

Background Since the FDA approval of clofarabine for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL) at childhood, several studies have been launched which put clofarabine under scrutiny in combination with other cytostatic drugs as second or third line therapy. As a novel treatment-strategy we introduced the combination of clofarabine with pegylated asparaginase (PEG-ASP) in a randomized fashion in comparison to the standard consolidation course with high dose cytarabine (Hidac) combined with PEG-ASP into the frontline management of ALL within the CoALL 08-09 protocol. The primary objective of the study was to compare the MRD based assessment of the cytotoxic eff…

medicine.medical_specialtybusiness.industryImmunologyUrologyCell BiologyHematologyBiochemistryMinimal residual diseaselaw.inventionHigh dose cytarabineRandomized controlled triallawmedicineClofarabinebusinessmedicine.drugBlood
researchProduct

Anticoagulation in Cancer Patients with Atrial Fibrillation and Grade 3-4 Thrombocytopenia

2021

Abstract Introduction: Atrial fibrillation (AF) is not uncommon in cancer patients with grade 3-4 thrombocytopenia (platelets <50x10 9/L). The risk of bleeding appears to outweigh the risk of thrombosis in acute leukemia patients. There are no published data regarding management of anticoagulation (AC) and rates of bleeding and thrombosis in other cancer types. Aim: To assess AC management and incidence of bleeding and thrombosis in thrombocytopenic cancer patients with AF. Methods: Single-center retrospective cohort study. The study included adults with active cancer, grade 3-4 thrombocytopenia (platelets <50x10 9/L) and AF with CHA 2DS 2-VASc ≥1, irrespective of AC status pr…

medicine.medical_specialtybusiness.industryInternal medicineImmunologymedicineCardiologyCancerAtrial fibrillationCell BiologyHematologymedicine.diseasebusinessBiochemistryBlood
researchProduct

Frequency of cardiac arrhythmias in older adults: findings from the subclinical atrial fibrillation and risk of ischemic stroke (SAFARIS) study

2020

Abstract Background Prolonged monitoring of cardiac rhythm has been used in patients with symptomatic arrhythmias and to assess for atrial fibrillation (AF) after cryptogenic stroke, but not in the general population and especially in older adults. Purpose To evaluate the frequency of arrhythmias in a community-based cohort of older adults through 14-days continuous cardiac monitoring using a patch-based device. Methods Cardiac rhythm was analyzed in 533 participants free of AF and congestive heart failure (CHF) from the tri-ethnic (white, black, Hispanic) Subclinical Atrial Fibrillation and Risk of Ischemic Stroke (SAFARIS) study. AF, supraventricular tachycardia (SVT, defined as 4 beats o…

medicine.medical_specialtybusiness.industryInternal medicineIschemic strokecardiovascular systemmedicineCardiologyAtrial fibrillationcardiovascular diseasesCardiology and Cardiovascular Medicinemedicine.diseasebusinessSubclinical infectionEuropean Heart Journal
researchProduct